Pakbaz Z - Search Results

1

Quality of life in patients with thalassemia intermedia compared to thalassemia major.

Pakbaz Z, Treadwell M, Yamashita R, Quirolo K, Foote D, Quill L, Singer T, Vichinsky EP. Pakbaz Z, et al. Ann N Y Acad Sci. 2005;1054:457-61. doi: 10.1196/annals.1345.059. Ann N Y Acad Sci. 2005. PMID: 16339697

2

Treatment of hepatitis C virus infection in thalassemia.

Butensky E, Pakbaz Z, Foote D, Walters MC, Vichinsky EP, Harmatz P. Butensky E, et al. Among authors: pakbaz z. Ann N Y Acad Sci. 2005;1054:290-9. doi: 10.1196/annals.1345.038. Ann N Y Acad Sci. 2005. PMID: 16339677

3

A simple model to assess and improve adherence to iron chelation therapy with deferoxamine in patients with thalassemia.

Pakbaz Z, Fischer R, Treadwell M, Yamashita R, Fung EB, Calvelli L, Quirolo K, Foote D, Harmatz P, Vichinsky EP. Pakbaz Z, et al. Ann N Y Acad Sci. 2005;1054:486-91. doi: 10.1196/annals.1345.065. Ann N Y Acad Sci. 2005. PMID: 16339703 Clinical Trial.

4

Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients.

Pakbaz Z, Fischer R, Fung E, Nielsen P, Harmatz P, Vichinsky E. Pakbaz Z, et al. Pediatr Blood Cancer. 2007 Sep;49(3):329-32. doi: 10.1002/pbc.21275. Pediatr Blood Cancer. 2007. PMID: 17554789

5

Education and employment status of children and adults with thalassemia in North America.

Pakbaz Z, Treadwell M, Kim HY, Trachtenberg F, Parmar N, Kwiatkowski JL, Cunningham MJ, Martin M, Sweeters N, Neufeld EJ, Giardina PJ, Olivieri N, Yamashita RC, Vichinsky E. Pakbaz Z, et al. Pediatr Blood Cancer. 2010 Oct;55(4):678-83. doi: 10.1002/pbc.22565. Pediatr Blood Cancer. 2010. PMID: 20535817 Free PMC article.

6

Bone mineral density in children with sickle cell anemia.

Lal A, Fung EB, Pakbaz Z, Hackney-Stephens E, Vichinsky EP. Lal A, et al. Among authors: pakbaz z. Pediatr Blood Cancer. 2006 Dec;47(7):901-6. doi: 10.1002/pbc.20681. Pediatr Blood Cancer. 2006. PMID: 16317761

7

Patient-reported outcomes of deferasirox (Exjade, ICL670) versus deferoxamine in sickle cell disease patients with transfusional hemosiderosis. Substudy of a randomized open-label phase II trial.

Vichinsky E, Pakbaz Z, Onyekwere O, Porter J, Swerdlow P, Coates T, Lane P, Files B, Mueller BU, Coïc L, Forni GL, Fischer R, Marks P, Rofail D, Abetz L, Baladi JF. Vichinsky E, et al. Among authors: pakbaz z. Acta Haematol. 2008;119(3):133-41. doi: 10.1159/000125550. Epub 2008 Apr 11. Acta Haematol. 2008. PMID: 18408362 Clinical Trial.

8

HbE/β-thalassemia: basis of marked clinical diversity.

Olivieri NF, Pakbaz Z, Vichinsky E. Olivieri NF, et al. Among authors: pakbaz z. Hematol Oncol Clin North Am. 2010 Dec;24(6):1055-70. doi: 10.1016/j.hoc.2010.08.008. Hematol Oncol Clin North Am. 2010. PMID: 21075280 Review.

9

Hb E/beta-thalassaemia: a common & clinically diverse disorder.

Olivieri NF, Pakbaz Z, Vichinsky E. Olivieri NF, et al. Among authors: pakbaz z. Indian J Med Res. 2011 Oct;134(4):522-31. Indian J Med Res. 2011. PMID: 22089616 Free PMC article. Review.

10

The new SQUID biosusceptometer at Oakland: first year of experience.

Fung EB, Fischer R, Pakbaz Z, Fagaly RL, Vichinsky E, Starr TN, Ewing T, Paulson DN, Hassenzahl WV, Harmatz P. Fung EB, et al. Among authors: pakbaz z. Neurol Clin Neurophysiol. 2004 Nov 30;2004:5. Neurol Clin Neurophysiol. 2004. PMID: 16012600

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38 results

Search Page